$75.86▴ 0.93%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
CG Oncology, Inc.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?CG Oncology to Present at Upcoming Investor Conferences in September
Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm